Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Susan Gregurick

Premium

The National Institute of General Medical Sciences has selected Susan Gregurick to direct its Biomedical Technology, Bioinformatics, and Computational Biology division. She takes over from Judith Greenberg who has been serving as acting director.

Previously, Gregurick was the acting director of the Department of Energy's biological systems science division where she developed and managed Kbase, DOE’s systems biology knowledgebase (BI 5/25/2012). She also oversaw bioinformatics and high-performance computing efforts at the DOE’s Joint Genome Institute and its Bioenergy Research Centers and has developed programs for modeling microbial function and metagenomic analysis. Gregurick was also a professor of computational biology at the University of Maryland, Baltimore.

She earned a B.S. in chemistry from the University of Michigan, Ann Arbor, and a Ph.D. in chemistry from the University of Maryland, College Park.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.